|
|
 | | | |
- close
- close
- close
- close
| |||||||||
These excerpts taken from the CVS 8-K filed Sep 11, 2009. Securities Act”), for the
registration of $1,500,000,000 aggregate principal amount of its 6.125% Senior
Notes due September 15, 2039 (the “ Securities Act”)) on Form S-3
in respect of the Notes (File No. 333-143110) (i) has been prepared by the
Company in conformity with the requirements of the Securities Act, and the rules
and regulations (the “ These excerpts taken from the CVS 8-K filed Mar 13, 2009. Securities Act”), for the
registration of $1,000,000,000 aggregate principal amount of its 6.60% Senior
Notes due March 15, 2019 (the “ Securities Act”)) on Form S-3
in respect of the Notes (File No. 333-143110) (i) has been prepared by the
Company in conformity with the requirements of the Securities Act, and the rules
and regulations (the “ These excerpts taken from the CVS 8-K filed Sep 10, 2008. Securities
Act”), for the registration of $350,000,000 aggregate principal amount of
its Floating Rate Senior Notes due September 10, 2010 (the “ Securities Act”)) on Form S-3
in respect of the Notes (File No. 333-143110) (i) has been prepared by the
Company in conformity with the requirements of the Securities Act, and the rules
and regulations (the “ This excerpt taken from the CVS 8-K filed Aug 15, 2006. Securities Act”)) on Form S-3 in respect of the Notes (File No. 333-134174) (i) has been prepared by the Company in conformity with the requirements of
the Securities Act, and the rules and regulations (the “ | EXCERPTS ON THIS PAGE:
|
| |||||||
